Henry F. (Chip) Chambers, M.D.

Co-Editor

• Professor of Medicine, University of California San Francisco (1992-2018)
• Professor of Medicine, Emeritus, University of California San Francisco (2018-Present)
• Chief of Infectious Diseases, San Francisco General Hospital (1992-2013)
• Director, UCSF Infectious Diseases Fellowship Training Program (2002-2013)
• Director, Clinical Research Services, Clinical & Translational Science Institute (2013-2018)
• Editor – American Society for Microbiology’s Antimicrobial Agents and Chemotherapy (2011-Present)

Area of Special Interest

• Antimicrobial drug resistance, staphylococcal infections, experimental therapeutics and epidemiology and pathogenesis of disease caused by community-acquired methicillin-resistant Staphylococcus aureus.

Professional Recognitions & Appointments

• Co-Chair - IDSA guidelines committee for treatment of MRSA
• Member, Board of Directors, Infectious Diseases Society of America
• Fellow of the IDSA and American College of Physicians
• Elected member of the American Society for Clinical Investigation and Association of American Physicians

Publication Highlights

Over 200 original publications and textbook chapters in the areas of drug resistance, endocarditis, bacterial infections, and staphylococcal diseases including:

• Essential Resources and Strategies for Antibiotic Stewardship Programs in the Acute Care Setting. Clinical Infectious Diseases - March 2018
• A Placebo-Controlled Trial of Antibiotics for Smaller Skin Abscesses. New England Journal of Medicine - June 2017
• Antimicrobial Stewardship Approaches in the Intensive Care Unit. Infectious Disease Clinics of North America - September 2017
• New Societal Approaches to Empowering Antibiotic Stewardship. JAMA – March 2016
• Whole-Genome Sequencing of Methicillin-Resistant Staphylococcus aureus Resistant to Fifth-Generation Cephalosporins Reveals Potential Non-mecA Mechanisms of Resistance. PLoS One – February 2016
• Rapid Molecular Diagnostics, Antibiotic Treatment Decisions, and Developing Approaches to Inform Empiric Therapy: PRIMERS I and II. Clinical Infectious Diseases - January 2016
• Antibacterial Treatment for Uncomplicated Skin Infections. New England Journal of Medicine – June 2015
• Comparative efficacies of tedizolid phosphate, vancomycin, and daptomycin in a rabbit model of methicillin-resistant Staphylococcus aureus endocarditis. Antimicrobial Agents and Chemotherapy - June 2015

Education

• Centre College Kentucky (BA)
• Vanderbilt University (Medical School, Valedictorian)
• University of California San Francisco, School of Medicine (Residency)

Disclosures

• Nothing to disclose.